| Dr Aram Nazareth Demirjian, MD | |
|
300 Mount Auburn St Ste 407, Cambridge, MA 02138-5665 | |
| (617) 868-7456 | |
| (617) 868-9243 |
| Full Name | Dr Aram Nazareth Demirjian |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 22 Years |
| Location | 300 Mount Auburn St Ste 407, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164661906 | NPI | - | NPPES |
| 023227100 | Medicaid | MD |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Auburn Hospital | Cambridge, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Atrius Health Inc | 4789588641 | 1116 |
| Mt Auburn Professional Services | 6103725031 | 256 |
News Archive
Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults, more than two children each and every week are diagnosed with cystic fibrosis (CF). New research at Ryerson University, in partnership with The Hospital for Sick Children, is examining the interaction between lab-tested drugs and the defective protein that causes CF to understand how and why the drugs work and to create stronger, more powerful second generation drugs to treat CF.
Caisson Biotech, L.L.C., a biopharmaceutical company with a patented heparosan-based drug delivery technology, announced today that it has entered into a Development and License Agreement with Novo Nordisk A/S, a global healthcare company and leader in diabetes care.
In a joint response to the Centers for Medicare & Medicaid Services (CMS) National Coverage and Analysis Group, the Lung Cancer Alliance, The Society of Thoracic Surgeons, American College of Radiology (ACR) and 38 other medical organizations called on CMS to quickly provide national Medicare coverage of low-dose computed tomography (LDCT) screening for patients at high risk for lung cancer.
John Niederhuber, a surgeon whom President Bush on Tuesday appointed as National Cancer Institute director, on Wednesday said that he hopes to find new nontoxic cancer medications but added that the agency likely will have to eliminate some programs because of budgetary issues, the New York Times reports.
Preoperative hyponatremia is common and, even when mild, carries a risk for perioperative complications and mortality, shows a large cohort study.
› Verified 4 days ago
| Entity Name | Atrius Health Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871639914 PECOS PAC ID: 4789588641 Enrollment ID: O20031121000582 |
News Archive
Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults, more than two children each and every week are diagnosed with cystic fibrosis (CF). New research at Ryerson University, in partnership with The Hospital for Sick Children, is examining the interaction between lab-tested drugs and the defective protein that causes CF to understand how and why the drugs work and to create stronger, more powerful second generation drugs to treat CF.
Caisson Biotech, L.L.C., a biopharmaceutical company with a patented heparosan-based drug delivery technology, announced today that it has entered into a Development and License Agreement with Novo Nordisk A/S, a global healthcare company and leader in diabetes care.
In a joint response to the Centers for Medicare & Medicaid Services (CMS) National Coverage and Analysis Group, the Lung Cancer Alliance, The Society of Thoracic Surgeons, American College of Radiology (ACR) and 38 other medical organizations called on CMS to quickly provide national Medicare coverage of low-dose computed tomography (LDCT) screening for patients at high risk for lung cancer.
John Niederhuber, a surgeon whom President Bush on Tuesday appointed as National Cancer Institute director, on Wednesday said that he hopes to find new nontoxic cancer medications but added that the agency likely will have to eliminate some programs because of budgetary issues, the New York Times reports.
Preoperative hyponatremia is common and, even when mild, carries a risk for perioperative complications and mortality, shows a large cohort study.
› Verified 4 days ago
| Entity Name | Mt Auburn Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992750996 PECOS PAC ID: 6103725031 Enrollment ID: O20040527001374 |
News Archive
Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults, more than two children each and every week are diagnosed with cystic fibrosis (CF). New research at Ryerson University, in partnership with The Hospital for Sick Children, is examining the interaction between lab-tested drugs and the defective protein that causes CF to understand how and why the drugs work and to create stronger, more powerful second generation drugs to treat CF.
Caisson Biotech, L.L.C., a biopharmaceutical company with a patented heparosan-based drug delivery technology, announced today that it has entered into a Development and License Agreement with Novo Nordisk A/S, a global healthcare company and leader in diabetes care.
In a joint response to the Centers for Medicare & Medicaid Services (CMS) National Coverage and Analysis Group, the Lung Cancer Alliance, The Society of Thoracic Surgeons, American College of Radiology (ACR) and 38 other medical organizations called on CMS to quickly provide national Medicare coverage of low-dose computed tomography (LDCT) screening for patients at high risk for lung cancer.
John Niederhuber, a surgeon whom President Bush on Tuesday appointed as National Cancer Institute director, on Wednesday said that he hopes to find new nontoxic cancer medications but added that the agency likely will have to eliminate some programs because of budgetary issues, the New York Times reports.
Preoperative hyponatremia is common and, even when mild, carries a risk for perioperative complications and mortality, shows a large cohort study.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Aram Nazareth Demirjian, MD 300 Mount Auburn St Ste 407, Cambridge, MA 02138-5665 Ph: (617) 868-7456 | Dr Aram Nazareth Demirjian, MD 300 Mount Auburn St Ste 407, Cambridge, MA 02138-5665 Ph: (617) 868-7456 |
News Archive
Cystic fibrosis is the most common fatal genetic disease affecting Canadian children and young adults, more than two children each and every week are diagnosed with cystic fibrosis (CF). New research at Ryerson University, in partnership with The Hospital for Sick Children, is examining the interaction between lab-tested drugs and the defective protein that causes CF to understand how and why the drugs work and to create stronger, more powerful second generation drugs to treat CF.
Caisson Biotech, L.L.C., a biopharmaceutical company with a patented heparosan-based drug delivery technology, announced today that it has entered into a Development and License Agreement with Novo Nordisk A/S, a global healthcare company and leader in diabetes care.
In a joint response to the Centers for Medicare & Medicaid Services (CMS) National Coverage and Analysis Group, the Lung Cancer Alliance, The Society of Thoracic Surgeons, American College of Radiology (ACR) and 38 other medical organizations called on CMS to quickly provide national Medicare coverage of low-dose computed tomography (LDCT) screening for patients at high risk for lung cancer.
John Niederhuber, a surgeon whom President Bush on Tuesday appointed as National Cancer Institute director, on Wednesday said that he hopes to find new nontoxic cancer medications but added that the agency likely will have to eliminate some programs because of budgetary issues, the New York Times reports.
Preoperative hyponatremia is common and, even when mild, carries a risk for perioperative complications and mortality, shows a large cohort study.
› Verified 4 days ago
Karen L Ahlert, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St, Suite 407, Cambridge, MA 02138 Phone: 617-868-7456 Fax: 617-868-9243 | |
Dr. Ronald Martin Weintraub, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1943 Cambridge St, Cambridge, MA 02139 Phone: 617-665-3194 Fax: 617-665-3577 | |
David I Becker, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cha - Surgery - Cambridge Campus, Cambridge, MA 02139 Phone: 617-665-2555 Fax: 617-665-3598 | |
Chantel Noelle Hile, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Mount Auburn St, Suite 407, Cambridge, MA 02138 Phone: 617-868-7456 Fax: 617-868-9243 | |
Dr. Ralph Wesley Vosburg, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 781-314-7600 | |
Moon O Kwoun, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-2555 |